Which is a primary symptom to monitor in patients receiving opioid therapy?

In the context of patients receiving opioid therapy, monitoring for constipation is crucial because opioids commonly lead to gastrointestinal side effects. Opioids bind to specific receptors in the gut, which slows down bowel motility and can impede normal bowel movements, resulting in constipation. This symptom is significant because it can lead to discomfort, increased abdominal pain, and more severe complications if left unaddressed, such as bowel obstruction.

Patients may not always report constipation voluntarily, so it is essential for healthcare providers to proactively assess and manage this side effect as part of a comprehensive care plan. Monitoring for constipation allows for timely interventions, such as dietary modifications, hydration, and the use of laxatives when necessary, to promote gastrointestinal health and enhance the overall comfort of the patient on opioid therapy.